AlterNet: E-mail this story
To:

Use commas to separate up to five addresses		 From:

Your e-mail address
Optional Message:

E-mail addresses are not recorded.   Privacy Policy »
 

Your recipient will receive an e-mail like this:

This has been forwarded to you from http://www.alternet.org by Your Address.

Your Message

-------------------------------------
Has Merck Learned Anything from Vioxx and Vytorin?
http://www.alternet.org/healthwellness/86110/

It's getting tough to find any Merck drug that can hold up to scrutiny.
-------------------------------------